Pharmaxis Ltd (AU:SNT) has released an update.
Pharmaxis Ltd reported a net cash increase of $3.52 million for the quarter ending September 30, 2024, driven by strategic financing activities that raised $5 million. Despite operating losses amounting to $4.231 million, the company managed to offset these with positive cash flow from investing activities. Investors may find these developments promising as the company navigates its financial strategies.
For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.
